EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report

Selcen Hoşgören-Tekin iD, Ahmet Atas iD, Dilek Seçkin iD, Ayşe Deniz Yücelten iD

International Journal of Dermatology · 12.08.2026

DOI: 10.1111/ijd.70632 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 12.08.2026. Verfasst von Selcen Hoşgören-Tekin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Janus kinase inhibitorabrocitinibactinic prurigopediatric dermatologyphotodermatoses

Autor:innen und Institutionen

  • Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye.

ORCID-Profile: Selcen Hoşgören-Tekin, Ahmet Atas, Dilek Seçkin, Ayşe Deniz Yücelten

Zitieren

APA

Hoşgören-Tekin, S., Atas, A., Seçkin, D., & Yücelten, A. D. (2026). Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. https://doi.org/10.1111/ijd.70632

Vancouver

Hoşgören-Tekin S, Atas A, Seçkin D, Yücelten AD. Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. 2026. doi:10.1111/ijd.70632

BibTeX
@article{HogrenTekin2026,
  author = {Hoşgören-Tekin, Selcen and Atas, Ahmet and Seçkin, Dilek and Yücelten, Ayşe Deniz},
  title = {Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.70632}
}
Kostenlos starten →